首页> 外文OA文献 >Inhibition of DNA Synthesis by a Farnesyltransferase Inhibitor Involves Inhibition of the p70s6k Pathway

【2h】

Inhibition of DNA Synthesis by a Farnesyltransferase Inhibitor Involves Inhibition of the p70s6k Pathway

机译：由法呢基转移酶抑制剂抑制DNA合成涉及抑制P70S6K途径

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Brian K. Law; Peter Nørgaard; Luigi Gnudi; Barbara B. Kahn; Hans S. Poulson; Harold L. Moses;
展开▼
作者单位

展开▼
年度 1999
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Inhibition of the Ras/Raf/MEK/ERK and RET Kinase Pathways with the Combination of the Multikinase Inhibitor Sorafenib and the Farnesyltransferase Inhibitor Tipifarnib in Medullary and Differentiated Thyroid Malignancies [J] . David S. Hong, Maria E. Cabanillas, Jennifer Wheler, The journal of clinical endocrinology and metabolism . 2011,第4期

机译：Ras / Raf / MEK / ERK和RET激酶途径与多激酶抑制剂索拉非尼和法尼基转移酶抑制剂Tipifarnib联合治疗在髓样和分化型甲状腺恶性肿瘤中的抑制作用
2. Growth inhibition by the farnesyltransferase inhibitor FTI-277 involves Bcl-2 expression and defective association with Raf-1 in liver cancer cell lines. [J] . Mazzocca A, Giusti S, Hamilton AD, Molecular pharmacology. . 2003,第1期

机译：法呢基转移酶抑制剂FTI-277的生长抑制作用涉及Bcl-2表达以及与Raf-1在肝癌细胞系中的缺陷结合。
3. 4′,6-Dihydroxy-4-methoxyisoaurone inhibits the HIF-1α pathway through inhibition of Akt/mTOR/p70S6K/4E-BP1 phosphorylation [J] . MiC., MaJ., ShiH., Journal of pharmacological sciences. . 2014,第2期

机译：4'，6-二羟基-4-甲氧基异金龙酮通过抑制Akt / mTOR / p70S6K / 4E-BP1磷酸化来抑制HIF-1α途径
4. Gefitinib, as a New Stent Coating Material, Specifically Inhibits Smooth Muscle Cells Proliferation Through Inhibition of EGFR/Akt Pathway Phosphorylation [C] . F. Li, S. Y. Wang, J. Luo, International Conference on Power Electronics and Energy Engineering . 2015

机译：作为新的支架涂层材料，吉非替尼特异性地通过抑制EGFR / AKT途径磷酸化来抑制平滑的肌细胞增殖
5. Structure-Based Drug Design in Medicinal Chemistry: I. Development of Translesion Synthesis Inhibitors II. Synthesis and Biological Evaluation of Sulfonyl Piperazine Derivatives for LpxH Inhibition [D] . Lee, Minhee 2017

机译：药物化学中基于结构的药物设计：I.跨病变合成抑制剂的开发II。磺酰哌嗪衍生物对LpxH的抑制作用及其合成及生物学评价
6. Inhibition of the Ras/Raf/MEK/ERK and RET Kinase Pathways with the Combination of the Multikinase Inhibitor Sorafenib and the Farnesyltransferase Inhibitor Tipifarnib in Medullary and Differentiated Thyroid Malignancies [O] . David S. Hong, Maria E. Cabanillas, Jennifer Wheler, -1

机译：Ras / Raf / MEK / ERK和RET激酶途径与多激酶抑制剂索拉非尼和法尼基转移酶抑制剂Tipifarnib联合治疗在髓样和分化型甲状腺恶性肿瘤中的抑制作用
7. Inhibition of the Ras/Raf/MEK/ERK and RET Kinase Pathways with the Combination of the Multikinase Inhibitor Sorafenib and the Farnesyltransferase Inhibitor Tipifarnib in Medullary and Differentiated Thyroid Malignancies [O] . Hong, David S., Cabanillas, Maria E., Wheler, Jennifer, 2011

机译：Ras / Raf / MEK / ERK和RET激酶途径的抑制与多激酶抑制剂索拉非尼和法尼基转移酶抑制剂Tipifarnib联合治疗髓样和分化型甲状腺恶性肿瘤

Inhibition of DNA Synthesis by a Farnesyltransferase Inhibitor Involves Inhibition of the p70s6k Pathway

著录项

引文网络

相似文献

相关主题

期刊订阅